Literature DB >> 24093699

Congenital stenosis and adjacent segment disease in the cervical spine.

Jason David Eubanks, Jon Belding, Erik Schnaser, Andrew Rowan, Gable Moffitt, John Weaver, Michael S Reich, Chris Bechtel, Ke Xie, Abhiram Gande, Justin Hohl, Brett Braly, Alan Hilibrand, James D Kang.   

Abstract

Symptomatic adjacent segment disease (ASD) after anterior cervical fusion (ACF) is reported in 25% of patients at 10 years postoperatively. Debate continues as to whether this degeneration is due to the natural history of the disk or the changed biomechanics after ACF. This study explored whether congenital stenosis predisposes patients to an increased incidence of ASD after ACF. A retrospective review of 635 patients with myelopathy or radiculopathy was performed; 364 patients had complete records for review. Patients underwent 1- to 5-level ACF (94 one-level, 145 two-level, 79 three-level, 45 four-level, and 1 five-level). Radiographs were evaluated for bony congenital stenosis using validated parameters, and ASD was measured according to Hilibrand's criteria and correlated with symptomatic ASD. Congenital stenosis was found in 21.7% of patients and radiographic ASD in 33.5%, with a significant association between these parameters. However, symptomatic ASD occurred in 11.8% of patients; no association between congenital stenosis and symptomatic ASD or myelopathy and ASD was found. Clinical results demonstrated excellent or good Robinson scores in 86.2% of patients and Odom scores in 87% of patients. Despite mostly excellent to good outcomes, symptomatic ASD is common after ACF. Although congenital stenosis appears to increase the incidence of radiographic ASD, it does not appear to predict symptomatic ASD. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Year:  2013        PMID: 24093699     DOI: 10.3928/01477447-20130920-15

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  8 in total

1.  Cervical canal stenosis and adjacent segment degeneration after anterior cervical arthrodesis.

Authors:  Jing Tao Zhang; Jun Ming Cao; Fan Tao Meng; Yong Shen
Journal:  Eur Spine J       Date:  2015-04-23       Impact factor: 3.134

2.  Anterior cervical discectomy and fusion versus anterior cervical corpectomy and fusion in the treatment of multilevel cervical spondylotic myelopathy: systematic review and a meta-analysis.

Authors:  Zhi-Qiang Wen; Jing-Yu Du; Zhi-Heng Ling; Hai-Dong Xu; Xiang-Jin Lin
Journal:  Ther Clin Risk Manag       Date:  2015-01-29       Impact factor: 2.423

3.  Cervical spondylotic myelopathy caused by single-level vertebral spontaneous fusion.

Authors:  Ning Yan; Shunzhi Yu; Tiesheng Hou; Guangfei Gu; Hailong Zhang; Shan Zhao; Shisheng He
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

Review 4.  Prevalence of adjacent segment disease following cervical spine surgery: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Lingde Kong; Junming Cao; Linfeng Wang; Yong Shen
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

5.  Survivorship Analysis of Clinical Adjacent-Segment Pathology After Single-Level Cervical Fusion.

Authors:  Lingde Kong; Qinghua Ma; Kunlun Yu; Junming Cao; Linfeng Wang; Yong Shen
Journal:  Med Sci Monit       Date:  2017-10-25

6.  Risk factors associated with clinical adjacent segment pathology following multi-level cervical fusion surgery.

Authors:  Lingde Kong; Changjun Sun; Ningzhao Kou; Jiangbo Bai; Jingtao Zhang; Jian Lu; Dehu Tian
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

7.  Relationship between developmental canal stenosis and surgical results of anterior decompression and fusion in patients with cervical spondylotic myelopathy.

Authors:  Jing Tao Zhang; Lin Feng Wang; Yue Ju Liu; Jun Ming Cao; Jie Li; Shuai Wang; Yong Shen
Journal:  BMC Musculoskelet Disord       Date:  2015-09-28       Impact factor: 2.362

8.  Symptomatic adjacent segment disease after single-lever anterior cervical discectomy and fusion: Incidence and risk factors.

Authors:  Feng Wang; Hong-Tao Hou; Peng Wang; Jing-Tao Zhang; Yong Shen
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.